- Page 1 and 2:
Antibiotics Simplified third EDITIO
- Page 3 and 4:
Contents Acknowledgments Introducti
- Page 5 and 6:
Contents v Chapter 28: Antifungal A
- Page 7:
Acknowledgments Our thanks go to th
- Page 10 and 11:
x Introduction ■■ How to Use Th
- Page 13:
New to the Third Edition The Third
- Page 17 and 18:
The Wonderful World of Microbiology
- Page 19 and 20:
chapter 1 Microbiology 5 More like
- Page 21 and 22:
chapter 1 Microbiology 7 Influenza
- Page 23 and 24:
chapter 1 Microbiology 9 Bacilli An
- Page 25 and 26: chapter 1 Microbiology 11 Gram-nega
- Page 27 and 28: chapter 1 Microbiology 13 Cocci Aer
- Page 29 and 30: General Approach to Infectious Dise
- Page 31 and 32: chapter 2 Infectious Diseases 17 Th
- Page 33 and 34: chapter 2 Infectious Diseases 19 Su
- Page 35 and 36: chapter 2 Infectious Diseases 21 al
- Page 37 and 38: Antibiotic Pharmacokinetics 3 The t
- Page 39 and 40: chapter 3 Pharmacokinetics 25 Table
- Page 41 and 42: chapter 3 Pharmacokinetics 27 can b
- Page 43 and 44: chapter 3 Pharmacokinetics 29 becau
- Page 45: chapter 3 Pharmacokinetics 31 Table
- Page 48 and 49: 34 PART 1 Antibiotic Therapy No vis
- Page 50 and 51: 36 PART 1 Antibiotic Therapy Table
- Page 52 and 53: 38 PART 1 Antibiotic Therapy done i
- Page 55 and 56: Adverse Consequences of Antibiotic
- Page 57 and 58: chapter 5 Adverse Consequences 43 f
- Page 59 and 60: chapter 5 Adverse Consequences 45 U
- Page 61: Antibacterial Drugs Part 2
- Page 64 and 65: 50 PART 2 Antibacterial Drugs to be
- Page 66 and 67: 52 PART 2 Antibacterial Drugs is ne
- Page 68 and 69: 54 PART 2 Antibacterial Drugs Spect
- Page 71 and 72: Antistaphylococcal Penicillins Agen
- Page 73 and 74: Aminopenicillins Agents: amoxicilli
- Page 75: chapter 6 Beta-Lactams 61 Don’t F
- Page 79 and 80: Beta-Lactamase Inhibitor Combinatio
- Page 81 and 82: chapter 6 Beta-Lactams 67 ■■ Im
- Page 83 and 84: Cephalosporins ■■ Introduction
- Page 85 and 86: First-Generation Cephalosporins Age
- Page 87 and 88: Second-Generation Cephalosporins Ag
- Page 89: chapter 6 Beta-Lactams 75 What They
- Page 92 and 93: 78 PART 2 Antibacterial Drugs assoc
- Page 95 and 96: Fourth-Generation Cephalosporins Ag
- Page 97 and 98: Fifth-Generation Cephalosporins Age
- Page 99 and 100: chapter 6 Beta-Lactams 85 Don’t F
- Page 101 and 102: 88 PART 2 Antibacterial Drugs Moder
- Page 104 and 105: Monobactams Agent: aztreonam Aztreo
- Page 106 and 107: Glycopeptides 7 Agents: vancomycin,
- Page 108 and 109: chapter 7 Glycopeptides 95 was brow
- Page 110 and 111: Fluoroquinolones 8 Agents: ciproflo
- Page 112 and 113: chapter 8 Fluoroquinolones 99 Devel
- Page 114 and 115: 102 PART 2 Antibacterial Drugs Spec
- Page 116 and 117: 102 PART 2 Antibacterial Drugs Spec
- Page 118 and 119: 104 PART 2 Antibacterial Drugs by s
- Page 120 and 121: 106 PART 2 Antibacterial Drugs Spec
- Page 122 and 123: 108 PART 2 Antibacterial Drugs syph
- Page 124 and 125: 110 PART 2 Antibacterial Drugs Spec
- Page 126 and 127:
112 PART 2 Antibacterial Drugs Don
- Page 128 and 129:
114 PART 2 Antibacterial Drugs Adve
- Page 131 and 132:
Nitroimidazoles 13 Agents: metronid
- Page 133:
chapter 13 Nitroimidazoles 119 •
- Page 136 and 137:
122 PART 2 Antibacterial Drugs Spec
- Page 139 and 140:
Streptogramins 15 Agent: quinuprist
- Page 141:
chapter 15 Streptogramins 127 What
- Page 144 and 145:
130 PART 2 Antibacterial Drugs Adve
- Page 147 and 148:
Folate Antagonists 17 Agents: trime
- Page 149 and 150:
chapter 17 Folate Antagonists 135
- Page 151 and 152:
Lincosamides 18 Agent: clindamycin
- Page 153 and 154:
chapter 18 Lincosamides 139 these i
- Page 155 and 156:
Polymyxins 19 Agents: colistin (col
- Page 157 and 158:
chapter 19 Polymyxins 143 base coli
- Page 159 and 160:
Fidaxomicin 20 Agent: fidaxomicin F
- Page 161:
Antimycobacterial Drugs Part 3
- Page 164 and 165:
150 PART 3 Antimycobacterial Drugs
- Page 167 and 168:
Rifamycins 22 Agents: rifampin (aka
- Page 169 and 170:
chapter 22 Rifamycins 155 it is mor
- Page 171 and 172:
Isoniazid 23 Agent: isoniazid Isoni
- Page 173:
chapter 23 Isoniazid 159 Don’t Fo
- Page 176 and 177:
162 PART 3 Antimycobacterial Drugs
- Page 178 and 179:
164 PART 3 Antimycobacterial Drugs
- Page 181 and 182:
Antifungal Drugs 26 ■■ Introduc
- Page 183:
chapter 26 Antifungal Drugs 169 fun
- Page 186 and 187:
172 PART 4 Antifungal Drugs Spectru
- Page 188 and 189:
174 PART 4 Antifungal Drugs What Th
- Page 190 and 191:
176 PART 4 Antifungal Drugs Adverse
- Page 193:
Azoles 29 ■■ Introduction to Az
- Page 196 and 197:
182 PART 4 Antifungal Drugs Adverse
- Page 199 and 200:
Itraconazole Itraconazole is a broa
- Page 201:
chapter 29 Azoles 187 What It’s G
- Page 204 and 205:
190 PART 4 Antifungal Drugs Moderat
- Page 206 and 207:
192 PART 4 Antifungal Drugs Don’t
- Page 208 and 209:
194 PART 4 Antifungal Drugs Adverse
- Page 211 and 212:
Echinocandins 30 Agents: caspofungi
- Page 213:
chapter 30 Echinocandins 199 clinic
- Page 217 and 218:
Antiviral Drugs 31 ■■ Introduct
- Page 219:
chapter 31 Antiviral Drugs 205 read
- Page 222 and 223:
208 PART 5 Antiviral Drugs Adverse
- Page 225 and 226:
Anti-Cytomegalovirus Agents 33 Agen
- Page 227:
chapter 33 Anti-CMV Agents 213 Ganc
- Page 230 and 231:
216 PART 5 Antiviral Drugs Adverse
- Page 233 and 234:
Antiretroviral Drugs 35 ■■ Intr
- Page 235 and 236:
Nucleoside and Nucleotide Reverse T
- Page 237 and 238:
chapter 35 Antiretroviral Drugs 223
- Page 239 and 240:
Non-nucleoside Reverse Transcriptas
- Page 241 and 242:
chapter 35 Antiretroviral Drugs 227
- Page 243 and 244:
Protease Inhibitors Agents: atazana
- Page 245 and 246:
chapter 35 Antiretroviral Drugs 231
- Page 247:
chapter 35 Antiretroviral Drugs 233
- Page 250 and 251:
236 PART 5 Antiviral Drugs Adverse
- Page 253 and 254:
Entry and Fusion Inhibitors Agents:
- Page 255 and 256:
Antiviral Interferons 36 Agents: pe
- Page 257 and 258:
chapter 36 Antiviral Interferons 24
- Page 259 and 260:
Serine Protease Inhibitors 37 Agent
- Page 261 and 262:
chapter 37 Serine Protease Inhibito
- Page 263 and 264:
Ribavirin 38 Agents: ribavirin Riba
- Page 265:
chapter 38 Ribavirin 251 What They
- Page 268 and 269:
254 PART 5 Antiviral Drugs Adverse
- Page 271 and 272:
Antiparasitic Drugs 40 ■■ Intro
- Page 273:
chapter 40 Antiparasitic Drugs 259
- Page 276 and 277:
262 PART 6 Antiparasitic Drugs abil
- Page 278 and 279:
264 PART 6 Antiparasitic Drugs worl
- Page 280 and 281:
266 PART 6 Antiparasitic Drugs ■
- Page 283 and 284:
Benzimidazoles 43 Agents: albendazo
- Page 285:
chapter 43 Benzimidazoles 271 Don
- Page 288 and 289:
274 PART 6 Antiparasitic Drugs QT p
- Page 291 and 292:
Ivermectin 45 Agent: ivermectin If
- Page 293 and 294:
chapter 45 Ivermectin 279 What It
- Page 295 and 296:
appendix 1 Normal Human Flora 281 S
- Page 297 and 298:
appendix 2 Spectrum of Activity 283
- Page 299 and 300:
appendix 2 Spectrum of Activity 285
- Page 301 and 302:
appendix 2 Spectrum of Activity 287
- Page 303 and 304:
appendix 3 Empiric Regimens 289 Hea
- Page 305 and 306:
appendix 3 Empiric Regimens 291 Int
- Page 307 and 308:
Index A A. baumannii, 12-14, 67, 91
- Page 309 and 310:
Index 295 Aribinosyl transferase II
- Page 311 and 312:
Index 297 anaerobes and, 71, 73-75,
- Page 313 and 314:
Index 299 Drug-resistant organisms,
- Page 315 and 316:
Index 301 cephalosporins and, 71, 7
- Page 317 and 318:
Index 303 L Lactic acidosis, 114, 2
- Page 319 and 320:
Index 305 polyenes and, 171, 172, 1
- Page 321 and 322:
Index 307 Plasmodium, 5, 106, 138,
- Page 323 and 324:
Index 309 Seizures, 118, 154, 158,
- Page 325:
Index 311 Valganciclovir, described